ES2134284T3 - Pirido-pirimidindionas, procedimiento para su preparacion y su empleo como medicamentos. - Google Patents

Pirido-pirimidindionas, procedimiento para su preparacion y su empleo como medicamentos.

Info

Publication number
ES2134284T3
ES2134284T3 ES94105958T ES94105958T ES2134284T3 ES 2134284 T3 ES2134284 T3 ES 2134284T3 ES 94105958 T ES94105958 T ES 94105958T ES 94105958 T ES94105958 T ES 94105958T ES 2134284 T3 ES2134284 T3 ES 2134284T3
Authority
ES
Spain
Prior art keywords
pirimidindionas
pirido
medicines
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94105958T
Other languages
English (en)
Inventor
Harald Dr Furrer
Dirk Dr Seiffge
Ismahan Dr Okyayuz-Baklouti
John Joseph Dr Grome
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2134284T3 publication Critical patent/ES2134284T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN COMPUESTO DE LA FORMULA I Y/O LAS SALES TOLERABLES FISIOLOGICAMENTE DEL COMPUESTO DE LA FORMULA I Y/O EVENTUALMENTE FORMAS ESTEREOISOMERAS DEL COMPUESTO DE LA FORMULA I, QUE SON APROPIADOS PARA LA ELABORACION DE MEDICAMENTO PARA TRATAMIENTO DE PERTURBACIONES DE LA CIRCULACION SANGUINEA Y/O ENFERMEDADES NEURODEGENERATIVAS.
ES94105958T 1993-04-23 1994-04-18 Pirido-pirimidindionas, procedimiento para su preparacion y su empleo como medicamentos. Expired - Lifetime ES2134284T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4313317 1993-04-23

Publications (1)

Publication Number Publication Date
ES2134284T3 true ES2134284T3 (es) 1999-10-01

Family

ID=6486199

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94105958T Expired - Lifetime ES2134284T3 (es) 1993-04-23 1994-04-18 Pirido-pirimidindionas, procedimiento para su preparacion y su empleo como medicamentos.

Country Status (8)

Country Link
US (1) US5556854A (es)
EP (1) EP0621037B1 (es)
JP (1) JP3483160B2 (es)
AT (1) ATE181832T1 (es)
DE (1) DE59408453D1 (es)
DK (1) DK0621037T3 (es)
ES (1) ES2134284T3 (es)
GR (1) GR3031267T3 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ334389A (en) * 1996-08-28 2001-05-25 Ube Industries Cyclic amine derivatives
ID25589A (id) 1998-02-27 2000-10-19 Sankyo Company Ltd Cs Senyawa-senyawa amino siklik
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
PA8539401A1 (es) * 2001-02-14 2002-10-28 Warner Lambert Co Quinazolinas como inhibidores de mmp-13
US6825180B2 (en) * 2001-05-18 2004-11-30 Cell Therapeutics, Inc. Pyridopyrimidine compounds and their uses
JP4530852B2 (ja) * 2002-07-15 2010-08-25 メルク・シャープ・エンド・ドーム・コーポレイション 糖尿病治療のためのピペリジノピリミジンジペプチジルペプチダーゼ阻害剤
WO2013115884A2 (en) * 2011-11-15 2013-08-08 Trustees Of Boston University Pyridopyrimidinone inhibitors of viruses
CN109715162B (zh) * 2016-08-12 2025-03-21 南京盖特医药技术有限公司 蛋白激酶调节剂
US20230339947A1 (en) * 2019-02-27 2023-10-26 Madera Therapeutics, LLC Use of caseinolytic protease p function as a biomarker of drug response to imipridone-like agents
CA3131740A1 (en) 2019-02-27 2020-09-03 Madera Therapeutics, LLC Use of caseinolytic protease p function as a biomarker of drug response to imipridone-like agents
CN119039287A (zh) * 2023-05-29 2024-11-29 中国药科大学 一类四氢吡啶并嘧啶酮衍生物及其制备方法与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA762455A (en) * 1962-03-22 1967-07-04 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Pyrido-pyrimidines

Also Published As

Publication number Publication date
GR3031267T3 (en) 1999-12-31
EP0621037A1 (de) 1994-10-26
JP3483160B2 (ja) 2004-01-06
DE59408453D1 (de) 1999-08-12
DK0621037T3 (da) 2000-01-17
JPH06321944A (ja) 1994-11-22
US5556854A (en) 1996-09-17
ATE181832T1 (de) 1999-07-15
EP0621037B1 (de) 1999-07-07

Similar Documents

Publication Publication Date Title
NO179867C (no) Sulfonamido- og sulfonamidokarbonyl-pyridin-2-karboksylsyreamider og anvendelse av forbindelsene som legemidler
CS145091A3 (en) Isoxazole-4-carboxamides and amides of hydroxyalkylidene cyanacetic acid, medicaments comprising said compounds and their application
NO306464B1 (no) Benzimidazolforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene for fremstilling av medikamenter
ES2064130T3 (es) Utilizacion de droloxifeno para el tratamiento de enfermedades de los huesos.
ATE82121T1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
DE3679920D1 (de) Spiro-3-heteroazolidinverbindungen und ihre salze, ihre herstellung und diese enthaltende pharmazeutische mittel.
DE68917485D1 (de) Pyridazinon-Derivate und diese enthaltende pharmazeutische Zubereitungen.
ES2145818T3 (es) Utilizacion de la (s)-(-)-alfa-etil-2-oxo-1-pirrolidin-acetamida para la preparacion de medicamentos destinados al tratamiento de la ansiedad.
ES2076226T3 (es) Utilizacion de trifluorometilfeniltetrahidropiridinas para la preparacion de medicamentos destinados para combatir las alteraciones ansio-depresivas.
GR3031267T3 (en) Pyrido-pyrimidinediones, process for their preparation and their use as pharmaceuticals.
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
ES2135500T3 (es) Producto farmaceutico para el tratamiento de trastornos de la piel.
MX9205869A (es) Triazaspirodecanon-metilcromanos, procedimiento para su fabricacion y medicamento que los contiene.
ES2144857T3 (es) Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso.
DE69815854D1 (de) Polyhydroxybutylpyrazinen, deren herstellung und diese enthaltende arzneimitteln
NO306468B1 (no) Nye fosfolipid-derivater, deres fremstilling, legemiddel inneholdende derivatene og derivatenes anvendelse
GR3037039T3 (en) Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants.
ES528323A0 (es) Procedimiento para la preparacion de derivados de 6 -metilprednisolona
FI890173L (fi) Isoxazoler med nootropisk verkan.
NO924472L (no) Nikotinylalanin som terapeutisk middel med virkning paa sentralnervesystemet

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 621037

Country of ref document: ES